Division of Hepatobiliarypancreas and Transplantation, Department of Surgery, Pusan National University Hospital, Busan, Republic of Korea.
Department of Surgery, Kosin University College of Medicine, Gospel Hospital, Busan, Republic of Korea.
Int J Med Sci. 2019 Jan 29;16(3):409-415. doi: 10.7150/ijms.28998. eCollection 2019.
: Progression of metastatic liver carcinoma from any original cancer is aggressive and the prognosis is very poor. Therefore the new model that is easily approachable to study the propagation and prognosis of metastatic liver carcinoma is necessary. The aim of this study is to confirm the tumor formation and metastatic activity of anaplastic thyroid cancer and to support the research basis for the next generation cancer treatment that is to be developed, by carrying out additional experiments like cytokine stimulation. We investigated sequential findings of immunohistochemistry of rabbit hepatic malignancy induced by AX7 cells. : 13 rabbits implanted with AX7 cells directly into liver parenchyme with laparotomy were investigated by histopathology examination, immunohistochemistry, which is useful for the evaluation of metastatic cancer angiogenesis. Growing tissue at the edge of the mass was collected and placed in the petri dish filled with saline. After removing necrotic and fibrous tissue, tumor tissue was cut into pieces, placed in saline, and extracted during the experiment. : Tumor growth and malignancy was confirmed on the 10th day after AX7 cells were implanted into liver. Positive for VEGF staining was found in the cytoplasm or cell membrane. The scores for VEGF stained cells were moderately positive (++) on day 10, strongly positive (+++) on day 44. Ki-67-positive hepatocytes reached at 65% on day 10, at 65.78% on day 14, at 66.4% on day 30, at 67.88% on day 44. : AX7 cells implanted into liver can be used as a new rabbit metastatic liver carcinoma model and would become useful for human metastatic liver carcinoma studies. Future studies may facilitate the establishment of an effective systemic therapy for the metastatic liver cancer.
由任何原始癌症进展而来的转移性肝癌具有侵袭性,预后非常差。因此,有必要建立一种新的模型,以便于研究转移性肝癌的传播和预后。本研究的目的是通过进行细胞因子刺激等额外实验,证实间变性甲状腺癌的肿瘤形成和转移活性,为下一代癌症治疗的开发提供研究基础。我们研究了用 AX7 细胞直接植入肝实质的兔肝恶性肿瘤的免疫组织化学的连续发现。
将 13 只兔通过剖腹术植入 AX7 细胞到肝脏实质中,通过组织病理学检查和免疫组织化学检查进行研究,免疫组织化学检查对转移性癌症血管生成的评估很有用。收集肿块边缘的生长组织并将其放入装满生理盐水的培养皿中。去除坏死和纤维组织后,将肿瘤组织切成小块,放入盐水中,并在实验过程中提取。
AX7 细胞植入肝脏 10 天后确认肿瘤生长和恶性。细胞质或细胞膜呈 VEGF 染色阳性。第 10 天 VEGF 染色细胞的评分呈中度阳性(++),第 44 天呈强阳性(+++)。Ki-67 阳性肝细胞在第 10 天达到 65%,在第 14 天达到 65.78%,在第 30 天达到 66.4%,在第 44 天达到 67.88%。
植入肝脏的 AX7 细胞可用作新型兔转移性肝癌模型,将有助于人类转移性肝癌的研究。未来的研究可能会促进转移性肝癌有效全身治疗的建立。